INTRODUCTION {#s1}
============

Tumor-initiating cells (TICs) are known to be resistant to many conventional therapies, and have been implicated in disease recurrence and metastatic spread \[[@R1]-[@R3]\]. Residual TICs are linked to poor patient survival in multiple tumor types. As TICs are extremely rare and represent only a small fraction of the total cancer cell population, we still know very little about what allows them to survive and propagate, especially under the harsh conditions associated with chemo- and radio-therapy \[[@R1]-[@R7]\].

Remarkably, TICs are thought to pheno-copy many of the characteristics of normal epithelial stem cells, such as immortalization, asymmetric cell division and resistance to stressors, such as DNA damage \[[@R2], [@R3], [@R7]\]. Hence, the term cancer stem cells (CSCs) is now used virtually interchangeably with TICs \[[@R1]-[@R7]\]. Another hallmark of epithelial TICs is their ability to grow under anchorage-independent conditions, when cultured using low-attachment plates \[[@R8]\]. Under these anchorage-independent growth conditions, CSCs/TICs spontaneously form 3D spheroid structures or "tumor-spheres", that retain stem-like or progenitor cell properties. Conversely, under cell suspension conditions, most non-TICs undergo a form of apoptotic cell death, known as "anoikis". It has been shown that each tumor-sphere is derived directly from the proliferative clonal expansion of a single TIC, and not from the aggregation of bulk cancer cells \[[@R8]\]. Furthermore, the enriched TIC population is more resistant to radiotherapy, showing enhanced DNA damage repair and lower levels of reactive oxygen species (ROS) \[[@R9]\]. As such, the preparation of tumor-spheres represents an efficient and convenient method to selectively enrich for TICs. When these tumor-spheres are specifically generated from primary breast cancer cells or cell lines, they are known as "mammospheres".

Several mechanisms have been proposed to explain the increased resistance of TICs to clinical treatments. Firstly, both radiotherapy and the majority of chemotherapeutic treatments target rapidly dividing cells and it has been proposed that the resistance of TICs was due to them having a quiescent slow-cycling phenotype \[[@R10]\]. However, it has since been demonstrated that CSCs (at least in breast cancer) do cycle and their resistance to stress is not simply a function of quiescence \[[@R11], [@R12]\]. Furthermore, CSCs have a greater capacity to efflux chemotoxins due to an increased expression of ABC transporters possibly explaining their additional resistance to chemotoxins but obviously these cannot account radio-resistance \[[@R13]\]. CSCs have been shown to be resistance to apoptotic stimuli compared to their non-stem cell counter parts and to have an increased capacity for DNA damage repair and this now seems to be the most likely mechanism of radio- and chemo-resistance \[[@R14], [@R15]\]. Several studies have now shown that typical DNA damaging chemotherapeutic agents can even cause an upregulation of stem cell transcription factors and a direct conversion of cancer non-stem cells (bulk cells) into TICs, potentially increasing the TIC burden in patients rather than reducing it \[[@R16]-[@R19]\]. Thus, specifically targeting TIC populations in approaches that circumvent their resistance to DNA damaging therapy is a promising strategy for future cancer treatment.

To begin to understand the phenotypic behavior of TICs at a molecular level, we prepared large numbers of mammospheres from two different ER(+) breast cancer lines (MCF7 & T47D). The mammospheres were subjected to unbiased proteomic profiling to decipher their molecular composition and metabolic characteristics compared to the cells grown in monolayer. Based on proteomics analysis, we observed that mammospheres significantly upregulate molecules associated with protein synthesis, including ribosome-related proteins and protein-folding chaperones, as well as specific molecules involved in mRNA translation initiation, polypeptide elongation, tRNA synthesis and amino acid uptake. We speculate that TICs are highly anabolic and increase their capacity for protein synthesis, to drive their clonal expansion via cell proliferation. Treatment with well-established inhibitors of protein synthesis (puromycin, rapamycin or methionine restriction) directly validated that mammosphere formation is strictly dependent on nacent protein synthesis. Thus, our results may also explain the anti-cancer health benefits of caloric restriction, intermittent fasting and the vegetarian diet, by systemically reducing protein synthesis in TICs.

Currently, there is a tremendous need to identify a selective "Achilles\' Heel" to eliminate TICs. Our new results highlight that TICs are especially functionally dependent on augmented protein synthesis, for their successful survival and continued propagation. This study provides a strong rationale for therapeutically targeting protein synthesis in the CSC population.

RESULTS {#s2}
=======

Greater than 70 ribosomal protein components, as well as an isoform of S6 Kinase (RPS6KB1), are upregulated in mammospheres {#s2_1}
---------------------------------------------------------------------------------------------------------------------------

First, we performed unbiased label-free proteomic analysis on MCF7 cells, a commonly used ER-positive breast cancer cell line. Table [1](#T1){ref-type="table"} shows a non-redundant list of the 72 ribosome-related proteins that were selectively upregulated in MCF7 mammospheres, as directly compared with MCF7 cells derived from monolayers. Only proteins with a fold increase of \~1.5 or greater were selected for this analysis. Note that the expression levels of 21 large ribosomal proteins and 15 small ribosomal proteins were increased, as compared with monolayer cultures. Similarly, two large mitochondrial-specific ribosomal proteins were increased. A specific-isoform of ribosomal S6 kinase was also elevated (RPS6KB1) nearly 15-fold. Finally, 34 proteins involved in mRNA translation initiation, polypeptide elongation, tRNA synthesis and amino acid uptake, were all selectively upregulated in MCF7 mammospheres.

###### Ribosomal-related Proteins Up-regulated in MCF7 Mammospheres

  Symbol                                                                             Gene Description                                                                 Fold-Upregulation   ANOVA
  ---------------------------------------------------------------------------------- -------------------------------------------------------------------------------- ------------------- ----------
  **Small Subunit (14)**                                                                                                                                                                  
  RPS9                                                                               40S ribosomal protein S9                                                         Infinity            0.025
  RPS3A                                                                              40S ribosomal protein S3A                                                        582.09              1.12E-08
  RPS27A                                                                             40S ribosomal protein S27A                                                       32.14               0.0002
  RPS3                                                                               40S ribosomal protein S3                                                         28.39               6.36E-07
  RPS23                                                                              40S ribosomal protein S23                                                        19.85               5.84E-09
  RPS20                                                                              40S ribosomal protein S20                                                        7.55                2.73E-06
  RPS7                                                                               40S ribosomal protein S7                                                         6.85                4.56E-05
  RPS21                                                                              40S ribosomal protein S21                                                        5.74                0.006
  RPS6                                                                               40S ribosomal protein S6                                                         3.88                0.009
  RPS4X                                                                              40S ribosomal protein S4, X-linked                                               3.69                0.02
  RPS7                                                                               40S ribosomal protein S7                                                         3.31                3.70E-07
  RPS29                                                                              40S ribosomal protein S29                                                        2.38                0.001
  RPS9                                                                               40S ribosomal protein S9                                                         2.03                0.002
  RPS7                                                                               40S ribosomal protein S7                                                         2.01                0.01
  **Large Subunit (21)**                                                                                                                                                                  
  RPL23A                                                                             60S ribosomal protein L23A                                                       265.34              1.17E-10
  RPLP0                                                                              60S acidic ribosomal protein P0                                                  144.75              1.11E-05
  RPL14                                                                              60S ribosomal protein L14                                                        119.42              4.50E-09
  RPL32                                                                              60S ribosomal protein L32                                                        55.04               3.22E-08
  RPL19                                                                              60S ribosomal protein L19                                                        42.89               2.97E-09
  RPL36                                                                              60S ribosomal protein L36                                                        38.80               0.0002
  RPL10                                                                              60S ribosomal protein L10                                                        32.94               2.22E-07
  RPL3                                                                               60S ribosomal protein L3                                                         32.87               6.64E-06
  RPL18A                                                                             60S ribosomal protein L18A                                                       20.49               4.24E-11
  RPL37A                                                                             60S ribosomal protein L37A                                                       17.12               8.28E-07
  RPL8                                                                               60S ribosomal protein L8                                                         10.68               8.89E-06
  RPL7                                                                               60S ribosomal protein L7                                                         8.47                5.75E-08
  RPL17                                                                              60S ribosomal protein L17                                                        5.19                1.09E-06
  RPL36AL                                                                            60S ribosomal protein L36A-like                                                  3.59                0.0001
  RPL5                                                                               60S ribosomal protein L5                                                         3.56                0.0005
  RPL6                                                                               60S ribosomal protein L6                                                         3.00                4.91E-06
  RPL12                                                                              60S ribosomal protein L12                                                        2.91                0.002
  RPL27                                                                              60S ribosomal protein L27                                                        2.73                0.02
  RPL9                                                                               60S ribosomal protein L9                                                         2.18                0.01
  RPL27A                                                                             60S ribosomal protein L27A                                                       1.91                0.025
  **Ribosomal S6 kinase (1)**                                                                                                                                                             
  RPS6KB1                                                                            Ribosomal protein S6 kinase, 70kDa, polypeptide 1                                14.97               4.92E-09
  **Mitochondrial Ribosomal Proteins (2)**                                                                                                                                                
  MRPL45                                                                             39S ribosomal protein L45, mitochondrial                                         46.42               4.32E-11
  MRPL17                                                                             39S ribosomal protein L17, mitochondrial                                         4.80                5.31E-05
  **Translation initiation factors (required for mRNA binding to ribosomes) (7)**                                                                                                         
  EIF4A1                                                                             Eukaryotic translation initiation factor 4A-I                                    439.74              4.07E-07
  EIF4G3                                                                             Eukaryotic translation initiation factor 4 gamma 3                               317.87              7.60E-09
  EIF4G1                                                                             Eukaryotic translation initiation factor 4 gamma 1                               66.29               2.02E-07
  EIF5A2                                                                             Eukaryotic translation initiation factor 5A-2                                    37.14               2.49E-07
  EIF3H                                                                              Eukaryotic translation initiation factor 3 subunit H                             8.45                1.99E-06
  EIF6                                                                               Eukaryotic translation initiation factor 6                                       5.23                2.74E-06
  EIF3B                                                                              Eukaryotic translation initiation factor 3 subunit B (EIF3S9)                    1.91                0.003
  **Elongation factors (promote delivery of aminoacyl tRNAs to the ribosome) (8)**                                                                                                        
  EEF1D                                                                              Elongation factor 1 delta                                                        Infinity            1.41E-10
  GFM1                                                                               Mitochondrial elongation factor G                                                97.22               1.32E-05
  EEF1G                                                                              Elongation factor 1 gamma                                                        17.00               0.008
  EEF2                                                                               Elongation factor 2                                                              15.67               0.03
  EEF1A1                                                                             Elongation factor 1 alpha                                                        7.56                9.90E-08
  TSFM                                                                               Elongation factor Ts, mitochondrial                                              3.75                0.002
  EEF1A2                                                                             Elongation factor 1-alpha 2                                                      2.87                0.0002
  TUFM                                                                               Elongation factor Tu, mitochondrial                                              2.31                0.0008
  **Enzymes for tRNA Synthesis (18)**                                                                                                                                                     
  VARS                                                                               Valine\--tRNA ligase                                                             Infinity            3.38E-11
  TRMT112                                                                            tRNA methyltransferase 112                                                       362.30              3.19E-10
  WARS                                                                               Tryptophan\--tRNA ligase, cytoplasmic                                            272.93              2.51E-09
  RARS                                                                               Arginine\--tRNA ligase, cytoplasmic                                              154.98              2.70E-10
  YARS                                                                               Tyrosine\--tRNA ligase, cytoplasmic                                              77.20               1.90E-12
  EPRS                                                                               Bifunctional-tRNA ligase (Glutamate and Proline)                                 60.55               1.60E-09
  FARSA                                                                              Phenylalanine\--tRNA ligase alpha                                                53.34               2.11E-08
  AIMP1                                                                              Aminoacyl tRNA synthase complex-interacting multifunctional protein 1            20.28               0.0007
  HARS2                                                                              Histidine\--tRNA ligase, mitochondrial                                           13.05               4.16E-07
  MARS                                                                               methionine-tRNA synthetase                                                       6.77                7.67E-08
  LARS                                                                               Leucine\--tRNA ligase, cytoplasmic                                               6.63                6.99E-05
  TARS                                                                               Threonyl-tRNA synthetase                                                         6.34                0.001
  RTCB                                                                               tRNA-splicing ligase (C22orf28)                                                  3.52                2.05E-09
  SARS                                                                               Serine\--tRNA ligase, cytoplasmic                                                2.79                6.95E-06
  NSUN2                                                                              tRNA (cytosine(34)-C(5))-methyltransferase                                       2.37                0.026
  DARS                                                                               Aspartate\--tRNA ligase, cytoplasmic                                             2.10                0.0009
  GARS                                                                               Glycine\--tRNA ligase                                                            1.81                0.0003
  AARS                                                                               Alanine\--tRNA ligase, cytoplasmic                                               1.47                0.002
  **Amino Acid Transporters (1)**                                                                                                                                                         
  SLC7A5                                                                             Solute carrier family 7 (Cationic amino acid transporter, y+ system), member 5   2.85                5.77E-06

For comparison purposes, we also performed unbiased label-free proteomic analysis on a second independent ER-positive breast cancer cell line, namely T47D cells. Our results are summarized in Table [2](#T2){ref-type="table"}. Note that 64 ribosome-related proteins were specifically over-expressed in T47D mammospheres, as compared with T47D monolayer cultures processed in parallel. Remarkably, 57 of these proteins overlapped with the proteins that were upregulated in MCF7 mammospheres (57/64 = 89% overlap). See the Venn diagram presented in Figure [1](#F1){ref-type="fig"}.

###### Ribosomal-related Proteins Up-regulated in T47D Mammospheres

  Symbol                                                                             Gene Description                                                                 Fold-Upregulation   ANOVA
  ---------------------------------------------------------------------------------- -------------------------------------------------------------------------------- ------------------- ----------
  **Small Subunit (11)**                                                                                                                                                                  
  **RPS9**                                                                           40S ribosomal protein S9                                                         Infinity            0.03
  **RPS3A**                                                                          40S ribosomal protein S3a                                                        Infinity            5.42E-05
  **RPS7**                                                                           40S ribosomal protein S7                                                         8.22                0.006
  **RPS21**                                                                          40S ribosomal protein S21                                                        7.20                2.66E-07
  [RPS25]{.ul}                                                                       40S ribosomal protein S25                                                        6.91                0.0002
  **RPS23**                                                                          40S ribosomal protein S23                                                        6.04                4.13E-11
  **RPS20**                                                                          40S ribosomal protein S20                                                        4.65                0.02
  **RPS6**                                                                           40S ribosomal protein S6                                                         3.49                4.54E-09
  **RPS3**                                                                           40S ribosomal protein S3                                                         3.01                0.048
  **RPS4X**                                                                          40S ribosomal protein S4, X-linked                                               2.16                0.004
  **Large Subunit (17)**                                                                                                                                                                  
  **RPLP0**                                                                          60S acidic ribosomal protein P0                                                  Infinity            5.13E-13
  **RPL32**                                                                          60S ribosomal protein L32                                                        30.62               4.74E-11
  **RPL23A**                                                                         60S ribosomal protein L23A                                                       21.67               5.20E-09
  **RPL14**                                                                          60S ribosomal protein L14                                                        13.89               1.55E-09
  **RPL19**                                                                          60S ribosomal protein L19                                                        9.42                2.13E-10
  **RPL10**                                                                          60S ribosomal protein L10                                                        6.72                0.03
  **RPL18A**                                                                         60S ribosomal protein 18A                                                        6.47                1.03E-11
  **RPL36**                                                                          60S ribosomal protein L36                                                        4.65                0.02
  **RPL3**                                                                           60S ribosomal protein L3                                                         3.96                0.00015
  [RPL23]{.ul}                                                                       60S ribosomal protein L23                                                        3.43                0.004
  **RPL8**                                                                           60S ribosomal protein L8                                                         3.36                0.001
  **RPL37A**                                                                         60S ribosomal protein L37A                                                       2.76                6.45E-07
  **RPL7**                                                                           60S ribosomal protein L7                                                         2.65                0.004
  **RPL5**                                                                           60S Ribosomal protein L5                                                         2.21                0.001
  **RPL3**                                                                           60S ribosomal protein L3                                                         2.17                0.015
  **RPL17**                                                                          60S ribosomal protein L17                                                        2.04                0.007
  [RPL10L]{.ul}                                                                      60S ribosomal protein L10-like                                                   1.92                0.01
  **Ribosomal S6 kinase (1)**                                                                                                                                                             
  **RPS6KB1**                                                                        Ribosomal protein S6 kinase, 70kDa, polypeptide 1                                4.82                5.72E-11
  **Mitochondrial Ribosomal Proteins (4)**                                                                                                                                                
  [MRPL47]{.ul}                                                                      39S ribosomal protein L47, mitochondrial                                         10.69               0.03
  **MRPL45**                                                                         39S ribosomal protein L45, mitochondrial                                         6.02                9.00E-11
  **MRPL17**                                                                         39S ribosomal protein L17, mitochondrial                                         3.30                0.01
  [MRPS22]{.ul}                                                                      28S ribosomal protein S22, mitochondrial                                         2.12                0.0001
  **Translation initiation factors (required for mRNA binding to ribosomes) (8)**                                                                                                         
  **EIF4G3**                                                                         Eukaryotic translation initiation factor 4 gamma 3                               107.50              0.001
  **EIF5A2**                                                                         Eukaryotic translation initiation factor 5A-2                                    10.00               2.74E-07
  **EIF4A1**                                                                         Eukaryotic translation initiation factor 4A-I                                    5.77                1.75E-13
  **EIF3H**                                                                          Eukaryotic translation initiation factor 3 subunit H                             3.33                1.26E-05
  **EIF4G1**                                                                         Eukaryotic translation initiation factor 4 gamma 1                               3.31                0.0001
  [EIF3E]{.ul}                                                                       Eukaryotic translation initiation factor 3 subunit E                             2.02                5.87E-05
  **EIF6**                                                                           Eukaryotic translation initiation factor 6                                       2.01                0.02
  [EIF2B4]{.ul}                                                                      Translation initiation factor eIF-2B subunit delta                               2.00                0.001
  **Elongation factors (promote delivery of aminoacyl tRNAs to the ribosome) (6)**                                                                                                        
  **EEF1D**                                                                          Elongation factor 1 delta                                                        30.44               3.10E-05
  **EEF1G**                                                                          Elongation factor 1 gamma                                                        4.93                0.003
  **EEF1A1**                                                                         Elongation factor 1 alpha 1                                                      4.40                3.21E-07
  **EEF1A2**                                                                         Elongation factor 1 alpha 2                                                      2.19                0.0008
  **TUFM**                                                                           Elongation factor Tu, mitochondrial                                              2.03                6.98E-05
  **EEF2**                                                                           Elongation factor 2                                                              1.92                0.006
  **Enzymes for tRNA Synthesis (16)**                                                                                                                                                     
  **LARS**                                                                           Leucine\--tRNA ligase, cytoplasmic                                               Infinity            0.026
  **TRMT112**                                                                        tRNA methyltransferase 112                                                       39.44               0.0002
  **VARS**                                                                           Valine\--tRNA ligase                                                             28.91               0.017
  **AIMP1**                                                                          Aminoacyl tRNA synthase complex-interacting multifunctional protein 1            18.23               0.0001
  **WARS**                                                                           Tryptophan\--tRNA ligase, cytoplasmic                                            17.18               6.59E-11
  **YARS**                                                                           Tyrosine\--tRNA ligase, cytoplasmic                                              10.04               4.46E-10
  **RARS**                                                                           Arginine\--tRNA ligase, cytoplasmic                                              8.82                9.46E-10
  **FARSA**                                                                          Phenylalanine\--tRNA ligase alpha subunit                                        7.44                6.70E-08
  **EPRS**                                                                           Bifunctional-tRNA ligase (Glutamate and Proline)                                 6.89                8.63E-09
  **TARS**                                                                           Threonyl-tRNA synthetase                                                         5.92                2.39E-08
  **HARS2**                                                                          Histidine\--tRNA ligase, mitochondrial                                           5.82                2.03E-07
  **MARS**                                                                           Methionine-tRNA synthetase                                                       3.24                2.32E-08
  **RTCB**                                                                           tRNA-splicing ligase (C22orf28)                                                  2.10                7.04E-05
  **AARS**                                                                           Alanine\--tRNA ligase, cytoplasmic                                               2.09                1.47E-05
  **SARS**                                                                           Serine\--tRNA ligase, cytoplasmic                                                1.82                0.001
  **NSUN2**                                                                          tRNA (cytosine(34)-C(5))-methyltransferase                                       1.67                0.027
  **Amino Acid Transporters (1)**                                                                                                                                                         
  **SLC7A5**                                                                         Solute carrier family 7 (Cationic amino acid transporter, y+ system), member 5   2.02                0.004

**Proteins shown in BOLD were also up-regulated in MCF7 Mammospheres. Others that were unique to T47D mammospheres are [underlined]{.ul}.**

![Venn diagram highlighting the conserved upregulation of ribosomal-related proteins in both MCF7 and T47D mammospheres\
Note that 57 ribosomal-related proteins were commonly upregulated in both data sets. These include proteins involved in ribosomal biogenesis, translation initiation, polypeptide elongation, tRNA synthesis and amino acid uptake.](oncotarget-06-4585-g001){#F1}

Heat shock proteins (HSPs)/protein-folding chaperones are upregulated in MCF7 and T47D mammospheres {#s2_3}
---------------------------------------------------------------------------------------------------

Heat shock proteins are important for proper protein folding during protein synthesis. Table [3](#T3){ref-type="table"} shows a list of 13 heat shock proteins that were selectively upregulated in MCF7 mammospheres, relative to MCF7 monolayers. Note that 2 of these heat shock proteins are mitochondrial-specific chaperones (HSPA9 and HSPD1). Similarly, 11 heat shock proteins were specifically over-expressed in T47D mammospheres, as compared with T47D monolayer cultures processed in parallel (Table [4](#T4){ref-type="table"}). Importantly, all eleven proteins overlapped with the proteins that were upregulated in MCF7 mammospheres (11/11 = 100% overlap). See the Venn diagram presented in Figure [2](#F2){ref-type="fig"}.

###### Heat Shock Proteins Up-regulated in MCF7 Mammospheres

  Symbol     Gene Description                                          Fold-Upregulation   ANOVA
  ---------- --------------------------------------------------------- ------------------- ----------
  HSPA1A     Heat shock 70 kDa protein 1A/1B                           Infinity            2.24E-13
  HSPA9      Stress-70 protein, mitochondrial                          298,325.4           2.62E-13
  HSPA4L     Heat shock 70 kDa protein 4L                              172.50              2.84E-10
  HSP90AA1   Heat shock protein HSP 90-alpha                           116.77              3.20E-10
  AHSA1      Activator of 90 kDa heat shock protein ATPase homolog 1   40.75               0.001
  HSPH1      Heat shock protein 105 kDa                                35.80               0.0002
  HSPD1      60 kDa heat shock protein, mitochondrial                  16.45               0.0001
  HSPA1L     Heat shock 70 kDa protein 1-like                          14.45               1.52E-10
  HSPB1      Heat shock protein beta-1                                 7.57                7.30E-08
  HSP90AB1   Heat shock protein HSP 90-beta                            4.65                1.09E-06
  HSP90B1    Heat shock protein GRP94                                  4.43                0.006
  HSPA8      Heat shock cognate 71 kDa protein                         3.59                3.34E-06
  HSPA4      Heat shock 70 kDa protein 4                               2.44                0.005

###### Heat Shock Proteins Up-regulated in T47D Mammospheres

  Symbol         Gene Description                                          Fold-Upregulation   ANOVA
  -------------- --------------------------------------------------------- ------------------- ----------
  **HSPD1**      60 kDa heat shock protein, mitochondrial                  69.06               1.45E-05
  **HSPA1A**     Heat shock 70 kDa protein 1A/1B                           43.00               4.58E-05
  **AHSA1**      Activator of 90 kDa heat shock protein ATPase homolog 1   20.41               0.001
  **HSP90AA1**   Heat shock protein HSP 90-alpha                           17.79               3.81E-11
  **HSPB1**      Heat shock protein beta-1                                 14.63               1.74E-05
  **HSPA4**      Heat shock 70 kDa protein 4                               9.53                2.48E-07
  **HSPA4L**     Heat shock 70 kDa protein 4L                              9.26                2.40E-09
  **HSPH1**      Heat shock protein 105 kDa                                5.17                0.0004
  **HSPA9**      Stress-70 protein, mitochondrial                          4.14                0.03
  **HSPA1L**     Heat shock 70 kDa protein 1-like                          3.35                1.19E-09
  **HSP90AB1**   Heat shock protein HSP 90-beta                            2.11                0.01

**Proteins shown in BOLD were also up-regulated in MCF7 Mammospheres.**

Taken together, our results predict that protein synthesis may be critical for the survival and propagation of cancer stem cells and/or progenitor cells.

![Venn diagram highlighting the conserved upregulation of heat shock proteins/molecular chaperones in both MCF7 and T47D mammospheres\
Note that 11 heat shock proteins, involved in protein folding, were commonly upregulated in both data sets.](oncotarget-06-4585-g002){#F2}

Functional effects of puromycin, a known inhibitor of protein synthesis, on mammosphere formation {#s2_4}
-------------------------------------------------------------------------------------------------

Next, to functionally validate the hypothesis that mammosphere formation strictly requires protein synthesis, we used a highly-specific inhibitor that mimics the nucleotide-polypeptide linkage that occurs in tRNAs, namely puromycin \[[@R20]\]. By mimicking the structure of tRNAs, puromycin competitively inhibits protein synthesis. Also, puromycin is physically transferred to the growing polypeptide chain, leading to the generation of puromycylated-peptides, which are prematurely released (Figure [3](#F3){ref-type="fig"}). Thus, puromycin inhibits protein synthesis via a premature chain termination mechanism \[[@R20]\].

![Puromycin: Structure and key features\
Puromycin resembles the 3′ end of an aminoacylated tRNA, which interacts with the A-site of the ribosome. During protein synthesis, puromycin transfers to the growing polypeptide chain, leading to the generation of a puromycylated-peptide, which is prematurely released. As such, puromycin inhibits protein synthesis via a premature chain termination mechanism.](oncotarget-06-4585-g003){#F3}

Figure [4](#F4){ref-type="fig"} shows the effects of increasing concentrations of puromycin on mammosphere formation, using an ER-positive breast cancer cell line (MCF7). Importantly, puromycin significantly reduced mammosphere formation, with an IC-50 of \~ 0.05 μg/ml and mammosphere formation was completed abolished at 0.5 μg/ml.

![Puromycin significantly reduces mammosphere formation in MCF7 cells, without affecting MCF7 cell viability or proliferation\
Increasing concentrations of puromycin inhibit mammosphere formation, using an ER-positive cell line (MCF7). Importantly, puromycin significantly reduces mammosphere formation, with an IC-50 of \~ 0.05 μg/ml. However, mammosphere formation was completed abolished at 0.5 μg/ml. The vehicle-alone control was normalized to one. (\*)p \<0.05.](oncotarget-06-4585-g004){#F4}

In striking contrast, monolayer MCF7 cells were \~10 times less sensitive to the effects of puromycin. Puromycin reduced both the i) proliferation and ii) viability of monolayer MCF7 cells, with an IC-50 of \~ 0.5 μg/ml, a concentration 10-times higher than the IC-50 for mammosphere formation (Figure [4](#F4){ref-type="fig"}). In addition, mammosphere formation was inhibited by \>70% at a concentration of 0.1 μg/ml; this same concentration had no effect on the viability of monolayer MCF7 cells.

In addition, when monolayer MCF7 cells were pre-treated with puromycin for 4 days and then trypsinized and plated for mammosphere assays (in the absence of puromycin), mammosphere forming activity was completely eliminated by puromycin pre-treatment at 0.5 μg/ml (Figure [5](#F5){ref-type="fig"}). At this same concentration, \~50% of monolayer MCF7 cells still remain viable and proliferate (Figure [4](#F4){ref-type="fig"}). This indicates that protein synthesis inhibitors can preferentially target TICs, even in the presence of adjacent non-TIC cells, in the setting of an attached monolayer.

![Puromycin pre-treatment of MCF7 cell monolayers completely prevents mammosphere formation\
When monolayer MCF7 cells were pre-treated with puromycin for 4 days and then trypsinized and plated for mammosphere assays (in the absence of puromycin), mammosphere forming activity was completely abolished by puromycin pre-treatment at 0.5 μg/ml. At this same concentration, nearly 50% of the monolayer cells still remains viable and proliferate (See Figure [4](#F4){ref-type="fig"}).](oncotarget-06-4585-g005){#F5}

Thus, we conclude that TICs/CSCs are clearly more sensitive to the functional effects of inhibiting protein synthesis, directly supporting the results of our unbiased proteomics analysis.

Functional effects of rapamycin and methionine restriction on mammosphere formation {#s2_5}
-----------------------------------------------------------------------------------

To further validate that mammosphere formation is functionally dependent on protein synthesis, we next used a well-established FDA-approved drug that potently inhibits protein synthesis, namely rapamycin \[[@R21]-[@R23]\]. Figure [6](#F6){ref-type="fig"} shows the effects of increasing concentrations of rapamycin on mammosphere formation. Note that rapamycin significantly reduces mammosphere formation in MCF7 cells, with an IC-50 \< 100 nM.

![Rapamycin significantly reduces mammosphere formation in MCF7 cells\
Note that rapamycin also effectively reduces mammosphere formation in this cellular context, with an IC-50 of \<100 nM. The vehicle-alone control was normalized to one. (\*)p \<0.05.](oncotarget-06-4585-g006){#F6}

Complementary results were obtained with methionine restriction. Methionine is absolutely required for protein synthesis, since every new protein sequence starts with a methionine residue \[[@R24]-[@R26]\]. Note that mammosphere formation was dramatically inhibited by methionine deprivation (Figure [7](#F7){ref-type="fig"}), which mimics the positive effects of caloric restriction in cultured cells. Importantly, mammosphere formation was functionally restored to normal levels by the dose-dependent re-addition of methionine to the methionine-free culture media, with maximal effects occurring at 0.01 mM (10 μM). It should be noted that mammosphere media normally contains 0.1 mM methionine (100 μM).

![Methionine restriction significantly reduces mammosphere formation in MCF7 cells\
Note that mammosphere formation was dramatically inhibited by methionine deprivation. Importantly, mammosphere formation was functionally restored to normal levels by the dose-dependent re-addition of methionine to the methionine-free culture media, with maximal effects occurring at 0.01 mM (10 μM). Mammosphere media normally contains 0.1 mM (100 μM). Parallel experiments with MCF7 cells grown as monolayer cultures are shown for comparison. Interestingly, mammosphere growth is 10-to18-fold more sensitive to the effects of methionine-restriction and replacement. (\*)p \<0.05.](oncotarget-06-4585-g007){#F7}

Remarkably, mammosphere formation appeared to be \>18-times more sensitive to the effects of methionine deprivation and replacement, when compared directly with MCF7 cell monolayers (Figure [7](#F7){ref-type="fig"}). More specifically, the re-addition of 0.001 mM methionine stimulated MCF7 mammosphere formation by 22-fold; in contrast, the same concentration of methionine only stimulated MCF7 monolayer proliferation by 1.2-fold (Figure [7](#F7){ref-type="fig"}). Similar results were also obtained at higher concentrations of methionine (0.01 and 0.1 mM), with mammospheres again showing a \>10-fold increase relative to monolayers.

In addition, MCF7 cell monolayers were pre-treated with methionine at different concentrations (0, 0.001, 0.01 and 0.1 mM) for 4 days and then trypsinized and re-plated for mammosphere assays (in the presence of normal levels of methionine (0.1 mM)). Under these conditions, mammosphere-forming activity was significantly reduced by up to 3-fold (Figure [8](#F8){ref-type="fig"}; compare 0 vs. 0.1 mM). Importantly, methionine restriction did not affect MCF7 monolayer viability (as seen in Figure [7](#F7){ref-type="fig"}). Thus, methionine restriction is also effective at reducing "stemness" in the context of MCF7 cell monolayers.

![Pre-treatment of MCF7 cell monolayers with methionine restriction significantly reduces mammosphere formation\
MCF7 cell monolayers were pre-treated with various concentrations of methionine (0, 0.001, 0.01 and 0.1 mM) for 4 days and then trypsinized and re-plated for mammosphere assays (in the presence of normal levels of methionine (0.1 mM)). Note that under these conditions, mammosphere-forming activity was significantly reduced by up to 3-fold (compare 0 vs. 0.1 mM). As such, methionine restriction is also effective at reducing "stemness" in the context of MCF7 cell monolayers.](oncotarget-06-4585-g008){#F8}

Therefore, pharmacological inhibition of protein synthesis and methionine depletion (as a mimetic of caloric restriction) may be effective strategies for eliminating cancer stem cells \[[@R22]-[@R28]\].

Relevance of protein synthesis related targets in human breast cancers {#s2_6}
----------------------------------------------------------------------

To assess the clinical relevance of our results, we also determined whether the proteomic targets that we identified in mammospheres were transcriptionally over-expressed in human breast cancer cells *in vivo*. Towards this end, we exploited a clinical data set of tumor samples from 28 breast cancer patients \[[@R29], [@R30]\]. These tumor samples were subjected to laser-capture micro-dissection, to separate epithelial cancer cells from adjacent stroma. [Tables 5](#T5){ref-type="table"} and [6](#T6){ref-type="table"} present a summary of these findings. Overall, 60 proteomic targets that we identified in mammospheres were also transcriptionally elevated in human breast cancer cells *in vivo* and the majority of these targets were also upregulated either in MCF7 and/or T47D mammospheres. As such, the new protein targets that we identified in mammospheres may be especially relevant for improving human breast cancer diagnosis and therapy.

###### "Ribosomal Targets" Over-Expressed in Mammospheres are also Transcriptionally Up-regulated in Human Breast Cancer Cells In Vivo (Cancer Epithelia vs. Tumor Stroma)

  Symbol                                                                             Gene Description                                                Fold-Upregulation (Epithelial/Stromal)   P-value
  ---------------------------------------------------------------------------------- --------------------------------------------------------------- ---------------------------------------- ----------
  **Small Subunit (12)**                                                                                                                                                                      
  RPS27A                                                                             40S ribosomal protein S27A                                      4.63                                     1.19E-05
  RPS3A                                                                              40S ribosomal protein S3a                                       4.59                                     1.35E-05
  RPS20                                                                              40S ribosomal protein S20                                       4.44                                     2.25E-05
  RPS6                                                                               40S ribosomal protein S6                                        4.09                                     7.27E-05
  RPS25                                                                              40S ribosomal protein S25                                       4.05                                     8.29E-05
  RPS4X                                                                              40S ribosomal protein S4, X-linked                              3.92                                     1.27E-04
  RPS23                                                                              40S ribosomal protein S23                                       3.56                                     3.92E-04
  RPS7                                                                               40S ribosomal protein S7                                        3.55                                     4.06E-04
  RPS3                                                                               40S ribosomal protein S3                                        3.33                                     7.91E-04
  RPS21                                                                              40S ribosomal protein S21                                       2.75                                     4.00E-03
  RPS29                                                                              40S ribosomal protein S29                                       2.31                                     1.25E-02
  RPS9                                                                               40S ribosomal protein S9                                        1.83                                     3.65E-02
  **Large Subunit (20)**                                                                                                                                                                      
  RPL7                                                                               60S ribosomal protein L7                                        5.21                                     1.53E-06
  RPL23A                                                                             60S ribosomal protein L23A                                      5.13                                     1.99E-06
  RPL3                                                                               60S ribosomal protein L3                                        5.01                                     3.14E-06
  RPL10                                                                              60S ribosomal protein L10                                       4.91                                     4.48E-06
  RPLP0                                                                              60S acidic ribosomal protein P0                                 4.89                                     4.71E-06
  RPL14                                                                              60S ribosomal protein L14                                       4.45                                     2.15E-05
  RPL17                                                                              60S ribosomal protein L17                                       4.15                                     6.00E-05
  RPL32                                                                              60S ribosomal protein L32                                       4.03                                     8.74E-05
  RPL6                                                                               60S ribosomal protein L6                                        4.00                                     9.86E-05
  RPL19                                                                              60S ribosomal protein L19                                       3.97                                     1.05E-04
  RPL8                                                                               60S ribosomal protein L8                                        3.86                                     1.51E-04
  RPL9                                                                               60S ribosomal protein L9                                        3.71                                     2.49E-04
  RPL23                                                                              60S ribosomal protein L23                                       3.56                                     3.92E-04
  RPL12                                                                              60S ribosomal protein L12                                       3.42                                     6.09E-04
  RPL36                                                                              60S ribosomal protein L36                                       3.37                                     6.91E-04
  RPL37A                                                                             60S ribosomal protein L37A                                      3.13                                     1.42E-03
  RPL27                                                                              60S ribosomal protein L27                                       2.57                                     6.41E-03
  RPL18A                                                                             60S ribosomal protein L18A                                      2.28                                     1.34E-02
  RPL5                                                                               60S ribosomal protein L5                                        1.86                                     3.45E-02
  RPL36AL                                                                            60S ribosomal protein L36A-like                                 1.70                                     4.76E-02
  **Mitochondrial Ribosomal Proteins (2)**                                                                                                                                                    
  MRPS22                                                                             28S ribosomal protein S22, mitochondrial                        3.27                                     9.31E-04
  MRPL17                                                                             39S ribosomal protein L17, mitochondrial                        2.94                                     2.38E-03
  **Translation initiation factors (required for mRNA binding to ribosomes) (4)**                                                                                                             
  EIF3H                                                                              Eukaryotic translation initiation factor 3 subunit H            4.70                                     9.25E-06
  EIF3E                                                                              Eukaryotic translation initiation factor 3 subunit E            3.57                                     3.75E-04
  EIF2B4                                                                             Translation initiation factor eIF-2B subunit delta              3.01                                     1.97E-03
  EIF3B                                                                              Eukaryotic translation initiation factor 3 subunit B (EIF3S9)   2.20                                     1.59E-02
  **Elongation factors (promote delivery of aminoacyl tRNAs to the ribosome) (5)**                                                                                                            
  EEF2                                                                               Elongation factor 2                                             4.01                                     9.29E-05
  EEF1G                                                                              Elongation factor 1 gamma                                       3.71                                     2.44E-04
  TUFM                                                                               Elongation factor Tu, mitochondrial                             3.38                                     6.74E-04
  EEF1A1                                                                             Elongation factor 1 alpha                                       3.16                                     1.30E-03
  EEF1D                                                                              Elongation factor 1 delta                                       2.50                                     7.67E-03
  **Enzymes for tRNA Synthesis (7)**                                                                                                                                                          
  RTCB                                                                               tRNA-splicing ligase (C22orf28)                                 4.58                                     1.37E-05
  MARS                                                                               methionine-tRNA synthetase                                      4.35                                     3.00E-05
  EPRS                                                                               Bifunctional-tRNA ligase (Glutamate and Proline)                4.06                                     8.10E-05
  DARS                                                                               Aspartate\--tRNA ligase, cytoplasmic                            3.43                                     5.87E-04
  WARS                                                                               Tryptophan\--tRNA ligase, cytoplasmic                           2.48                                     8.17E-03
  SARS                                                                               Serine\--tRNA ligase, cytoplasmic                               2.15                                     1.81E-02
  YARS                                                                               Tyrosine\--tRNA ligase, cytoplasmic                             1.72                                     4.55E-02

**-Transcriptional profiling data derived from the analysis of N=28 breast cancer patients are shown, high-lighting the levels of fold-upregulation observed in the epithelial cancer cell compartment (relative to the tumor stroma), and corresponding p-values derived from the analysis of these clinical samples.**

**-Proteins listed above (50 in total) were all upregulated either in MCF7 or T47D mammospheres (See Tables 1 & 2).**

###### Heat Shock Proteins Over-Expressed in Mammospheres are also Transcriptionally Up-regulated in Human Breast Cancer Cells In Vivo (Cancer Epithelia vs. Tumor Stroma)

  Symbol                     Gene Description                                          Fold-Upregulation (Epithelial/Stromal)   P-value
  -------------------------- --------------------------------------------------------- ---------------------------------------- ----------
  **(Epithelial/Stromal)**                                                                                                      
  HSP90AB1                   Heat shock protein HSP 90-beta                            4.94                                     4.03E-06
  HSP90AA1                   Heat shock protein HSP 90-alpha                           3.76                                     2.12E-04
  HSPA4                      Heat shock 70 kDa protein 4                               3.75                                     2.18E-04
  HSPA9                      Stress-70 protein, mitochondrial                          3.69                                     2.64E-04
  HSPB1                      Heat shock protein beta-1                                 3.27                                     9.51E-04
  HSPD1                      60 kDa heat shock protein, mitochondrial                  3.42                                     5.93E-04
  HSPH1                      Heat shock protein 105 kDa                                3.18                                     1.22E-03
  HSPA8                      Heat shock cognate 71 kDa protein                         3.11                                     1.49E-03
  AHSA1                      Activator of 90 kDa heat shock protein ATPase homolog 1   2.49                                     7.88E-03
  HSP90B1                    Heat shock protein 90kDa beta (Grp94), member 1           2.43                                     9.33E-03

**-Transcriptional profiling data derived from the analysis of N=28 breast cancer patients are shown, high-lighting the levels of fold-upregulation observed in the epithelial cancer cell compartment (relative to the tumor stroma), and corresponding p-values derived from the analysis of these clinical samples.**

**-Proteins listed above (10 in total) were all upregulated either in MCF7 or T47D mammospheres (See Tables 3 & 4).**

DISCUSSION {#s3}
==========

Here, using unbiased label-free proteomics analysis, we show that the cells of mammospheres (a population which is enriched for TICs and other progenitor cells) functionally overexpress numerous proteins, related to protein synthesis, including ribosomal biogenesis, mRNA translation initiation, polypeptide elongation, tRNA synthesis, amino acid uptake and protein folding. The potential clinical relevance of these targets was further validated using a previously published data set of human breast cancer samples (N=28 patients), that were subjected to laser-capture microdissection, to separate the epithelial tumor cells from the adjacent tumor stroma. Thus, these novel anabolic targets reveal a metabolic "Achilles\' Heel" to allow the elimination of CSCs. In accordance with this idea, we demonstrate that the therapeutic targeting of protein synthesis in mammospheres (via puromycin, rapamycin or methionine-restriction) is indeed sufficient to prevent their proliferative expansion, as assessed using mammosphere formation as a functional assay (summarized schematically in Figure [9](#F9){ref-type="fig"}). In accordance with our results, a recent paper has shown that the mTOR inhibitor Torin-1 selectively targets human colon CSCs \[[@R31]\].

![Anabolic tumor-initiating cells require protein synthesis for clonal expansion\
Activation of the PI3-kinase/AKT/mTOR signaling pathway is known to converge on ribosomal biogenesis and protein synthesis. Thus, the therapeutic effects of PI3-kinase inhibitors and AKT inhibitors, may be explained by their ability to inhibit mTOR signaling and block protein synthesis in TICs. Similarly, direct pharmacological inhibition of protein synthesis and/or caloric restriction or protein restriction may have similar beneficial therapeutic effects. Thus, our current data provide a novel convergent mechanism by which inhibitors of PI3-kinase, AKT, mTOR, as well as caloric restriction, may all directly target tumor-initiating cells, by inhibiting protein synthesis.](oncotarget-06-4585-g009){#F9}

Recently, we also reported that mitochondrial oxidative metabolism is also markedly amplified in mammospheres, as evidenced by i) unbiased proteomics analysis and ii) functional validation with inhibitors of mitochondrial OXPHOS \[[@R32]\]. Thus, enhanced mitochondrial energy production could help directly "fuel" increased protein synthesis in CSCs, thereby driving and maintaining the anabolic phenotype of TICs (Figure [10](#F10){ref-type="fig"}).

![Augmented mitochondrial OXPHOS may help fuel increased protein synthesis\
Recently, we showed that mitochondrial oxidative metabolism is significantly amplified in mammospheres, as evidenced by i) unbiased proteomics analysis and ii) functional validation with inhibitors of mitochondrial OXPHOS. As such, enhanced mitochondrial energy production could help directly "fuel" increased protein synthesis in CSCs, thereby driving and maintaining the anabolic phenotype of TICs. Thus, inhibition of mitochondrial function and protein synthesis may both be beneficial.](oncotarget-06-4585-g010){#F10}

Deregulation of protein synthesis {#s3_1}
---------------------------------

Deregulation of protein synthesis is a relatively unexplored but emerging mechanism of cancer progression. Two of the better documented examples of this phenomenon are increased protein synthesis as a result of c-MYC and mTOR oncogenic signaling. Although better known for targeting genes involved in cell cycle regulation, it has been known for some time that c-MYC directly targets multiple components of the translational machinery including: RNA polymerases I, II and III; ribosomal proteins; translation initiation factors; elongation factors; and rRNA \[[@R33]-[@R38]\]. Until more recently, the consequence and importance of this protein synthesis up regulation has remained unknown and the complexity and breadth of c-MYC targets has made it a difficult question to address \[[@R39]\]. Specific ribosomal protein haploinsufficiency (L24^+/−^ and L38^+/−^) have recently helped to address the role of c-MYC induced protein synthesis \[[@R40]\]. It was thus demonstrated ribosomal protein haploinsufficiency is able to rescue mice from increased rates of protein synthesis downstream of oncogenic Eμ-Myc signaling. In these mice, the growth of Myc-overexpressing B cells was returned to normal and remarkably this was coupled with the restoration of cell division rates to near wild-type levels \[[@R40]\]. These results imply that c-MYC directly couples cell growth and cell division, at least in part, by a deregulation of protein synthesis. Furthermore, the oncogenic potential of c-MYC was strongly impaired by ribosomal protein haploinsufficiency genetic backgrounds, with the onset of lymphomas being dramatically delayed Eμ-Myc;L24^+/−^ and Eμ-Myc;L38^+/−^ mice compared to Eμ-Myc \[[@R40]\]. This may be due to an increase in the apoptotic response to Myc oncogenic activity observed with ribosomal protein haplo-insufficiency genetic backgrounds.

Unlike c-MYC, the oncogenic mTOR signaling pathway is readily associated with the control of protein synthesis, targeting mRNA translation and ribosome biogenesis \[[@R41]-[@R48]\]. The signaling cascade initiates with PI3-kinase producing phosphatidylinositol-3,4-bisphosphate and phosphatidylinositol-3,4,5-triphosphate which act as second messages or as docking sites for the serine/threonine kinase Akt \[[@R49]\]. Recruitment of Akt to PI3-kinase products allows Akt-phosphorylation and thus activated, by the kinase PDK1. Activated Akt subsequently targets mTOR, in turn promoting translation via the activation of p70 S6 kinase (S6K) and the initiation factor 4E \[[@R50], [@R51]\]. S6K phosphorylates ribosomal protein S6 and promotes the translation of translational machinery \[[@R52]\].

Methionine and calorie restriction {#s3_2}
----------------------------------

Methionine-free medium reduced the proliferation and viability of the cells in mammospheres. Reduction of methionine also reduces proliferation and increases apoptosis of embryonal stem cells (ESC) whilst apparently not affecting more differentiated cells \[[@R53]\]. ESC can be induced to form differentiated cardiac cells and a methionine free medium can be used to remove remaining ESCs which, if transplanted with cardiac cells form teratomas \[[@R54]\]. Our data is the first suggestion that epithelial TICs may be similarly sensitive to methionine depletion. It is well known that tumor cell lines and primary tumors in-vitro and when grown in-vivo in rodents are growth inhibited by methionine depletion whereas normal cells are unresponsive. Methionine restriction (MR) was shown to reduce the growth of sarcomas \[[@R55], [@R56]\] \[[@R57]\], adenocarcinomas \[[@R25], [@R58]\] and mammary tumors in rodents \[[@R59]\], as well as of human tumor cell lines \[[@R60]\], human primary tumors in-vitro \[[@R61]\] and tumor growth in nude mice \[[@R62], [@R63]\].

Low methionine diets in rodents produce similar effects as calorie restriction \[[@R64]\]. Tumor formation and tumor growth is reduced and lifespan is increased although MR does not appear as potent as calorie restriction or general protein restriction \[[@R26]\]. MR may produce longevity effects, in part, acting through reduction of the formation of free radicals in mitochondria \[[@R64], [@R65]\] and, in part, by inhibition of protein synthesis in precursor cells as demonstrated in this report. Also, methionine restriction increases the stress tolerance of human fibroblasts, reduces senescence and increases their doubling time \[[@R66], [@R67]\]. In mammals, the effect of MR appears to be growth hormone dependent \[[@R68]\].

Vegans and vegetarians have relatively low intakes of methionine compared with meat eaters and some but not all recent studies suggest that vegans have lower cancer and cardiovascular disease risk \[[@R69]-[@R71]\]. It has been suggested that low-methionine vegan diets may be used as a feasible approach for life extension \[[@R72]\]. Ornish and his colleagues \[[@R73]\] were able to show that the concentration of prostate specific antigen (PSA) was reduced in men with prostate cancer treated only with lifestyle changes, which included a vegan diet and exercise. A recent phase I study demonstrated that methionine restriction was well tolerated for up to 17 weeks in patients with various solid tumors \[[@R74]\].

CONCLUSIONS {#s4}
===========

In conclusion, based on our current analysis using mammosphere cultures, we propose that inhibition of protein synthesis is a new therapeutic strategy for eradicating TICs, to potentially prevent tumor recurrence, metastasis and poor clinical outcome in breast cancer patients. This strategy might also be extended to other tumor types, as many of the phenotypic features of TICs are highly conserved between different epithelial cancer types.

MATERIALS AND METHODS {#s5}
=====================

Materials {#s5_1}
---------

Breast cancer cell lines (MCF7 and T47D) were purchased from the ATCC. Puromycin, rapamycin, methionine and methionine-free media were obtained commercially from Sigma-Aldrich. Gibco-brand cell culture media (DMEM/F12) was purchased from Life Technologies.

Monolayer culture {#s5_2}
-----------------

50,000 cells were plated in normal medium (DMEM, 10% FCS, L-glutamine, supplemented with Pen-Strep) for 24hr, followed by treatment with increasing concentrations of a specific inhibitor (puromycin) or nutrient (methionine) for a further 4 days. Cells were then collected by trypsinization and centrifugation. To quantitatively determine cell growth, the number of cells after dtreatment was counted using an automatic cell counter (Biorad) and differences compared to untreated cells was calculated and expressed as fold-change. To assess cell viability, cells were incubated for 1 minute with Trypan Blue (Sigma, \#T8145) using a 1:1 ratio. The number of Trypan Blue positive cells (non-viable) was measured using an automatic cell counter (Biorad) and compared to untreated controls. For puromycin treatments, cells were also plated into mammosphere culture to assess stem cell-like activity with no further drug treatment. All monolayer experiments were performed in triplicate, three times independently, such that each data point represents the average of 9 replicates.

Mammosphere culture {#s5_3}
-------------------

To directly assess the effects of specific inhibitors (puromycin/rapamycin) or nutrients (methionine) on mammosphere formation, cultures were supplemented with increasing concentrations of puromycin, rapamycin or methionine, as indicated in a given experiment. A single cell suspension was prepared using enzymatic (1x Trypsin-EDTA, Sigma Aldrich, \#T3924), and manual disaggregation (25 gauge needle) to create a single cell suspension \[[@R8], [@R32]\]. Cells were plated at a density of 500 cells/cm^2^ in mammosphere medium (DMEM-F12/B27/20ng/ml EGF/PenStrep) in non-adherent conditions, in culture dishes coated with (2-hydroxyethylmethacrylate) (poly-HEMA, Sigma, \#P3932). Cells were grown for 4-to-5 days and maintained in a humidified incubator at 37°C at an atmospheric pressure in 5% (v/v) carbon dioxide/air. After 5 days for culture, spheres \>50 μm were counted using an eye piece graticule, and the percentage of cells plated which formed spheres was calculated and is referred to as percentage mammosphere formation, and was normalized to one (1 = 100 %MSF). All mammosphere experiments were performed in triplicate, three times independently, such that each data point represents the average of 9 replicates.

Methionine restriction and replacement {#s5_4}
--------------------------------------

For methionine restriction experiments, DMEM-F12 was replaced with methionine-free DMEM (Gibco, \#21013-24) and supplemented with 30mg/L cysteine (Sigma, \#C7352-25G).

Label-free quantitative proteomics analysis {#s5_5}
-------------------------------------------

For proteomic analysis, mammospheres were collected by centrifugation at 800 rpm for 10 minutes. Cell lysates were prepared for trypsin digestion by sequential reduction of disulphide bonds with TCEP and alkylation with MMTS \[[@R32]\]. Then, the peptides were extracted and prepared for LC-MS/MS. All LC-MS/MS analyses were performed on an LTQ Orbitrap XL mass spectrometer (Thermo Scientific, San Jose, CA) coupled to an Ultimate 3000 RSLCnano system (Thermo Scientific, formerly Dionex, The Netherlands). Xcalibur raw data files acquired on the LTQ-Orbitrap XL were directly imported into Progenesis LCMS software (Waters Corp., Milford, MA, formerly Non-linear dynamics, Newcastle upon Tyne, UK) for peak detection and alignment. Data were analyzed using the Mascot search engine. Five replicates were analyzed for each sample type (N = 5). Statistical analyses were performed using ANOVA and only fold-changes in proteins with a p-value less than 0.05 were considered significant.

Data mining {#s5_6}
-----------

To firmly establish the clinical relevance of our results from the quantitative proteomics analysis of mammospheres, we re-analyzed the transcriptional profiles of epithelial breast cancer cells and adjacent tumor stromal cells that were physically separated by laser-capture microdissection (from N=28 human breast cancer patients) \[[@R29], [@R30]\].
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